Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Vaxart Q3 EPS $(0.11) Beats $(0.18) Estimate, Sales $2.10M Beat $100.00K Estimate

Author: Benzinga Newsdesk | November 02, 2023 04:24pm
Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.18) by 38.89 percent. This is a 52.17 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $2.10 million which beat the analyst consensus estimate of $100.00 thousand by 2.00K percent.

Posted In: VXRT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist